Search research articles
Contact Us
Filters
Showing results (111-120 of 178) with videos related to
Page
of 18
Sort By:
Lipids in Health and Disease
|
August 20, 2016
Pharmacoeconomics of PCSK9 inhibitors in 103 hypercholesterolemic patients referred for diagnosis and treatment to a cholesterol treatment center
Parth Shah, Charles J Glueck, Vybhav Jetty, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
February 23, 2024
Semaglutide improves metabolic dysfunction-associated steatohepatitis: A 10-year retrospective study
Parth Shah, Megan White, Alex Sievert, et al.
Cancers
|
November 13, 2025
Advances in Precision Oncology: From Molecular Profiling to Regulatory-Approved Targeted Therapies
Petar Brlek, Vedrana Škaro, Nenad Hrvatin, et al.
Journal of Clinical Periodontology
|
April 1, 2025
A Real-World Evidence Study Evaluating Oral-Health-Related Quality of Life Following the Use of Anti-Sensitivity Toothpaste for Self-Reported Dentine Hypersensitivity Management
Roberta Grimaldi, Sarah R Baker, Parth Shah, et al.
Croatian Medical Journal
|
June 13, 2024
Genomic sequencing for newborn screening: current perspectives and challenges
Nidhi Shah, Petar Brlek, Luka Bulić, et al.
Journal of Clinical Ultrasound : JCU
|
February 16, 2016
Predictors of incipient dysfunction of all cardiac chambers after treatment of metastatic renal cell carcinoma by tyrosine kinase inhibitors
Sherif Moustafa, Thai H Ho, Parth Shah, et al.
Preventive Medicine
|
August 3, 2021
Time and geographic variations in human papillomavirus vaccine uptake in Washington state
Nastaran Pourebrahim, Parth Shah, Trang VoPham, et al.
Lipids in Health and Disease
|
March 13, 2016
Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥ 70 mg/dl despite maximal tolerated cholesterol lowering therapy
Charles J Glueck, Parth Shah, Naila Goldenberg, et al.
Blood Advances
|
August 23, 2023
Monoallelic deletion of BCMA is a frequent feature in multiple myeloma
Mehmet Kemal Samur, Anil Aktas Samur, Jill Corre, et al.
Lipids in Health and Disease
|
January 25, 2017
Efficacy, safety, Low density lipoprotein cholesterol lowering, and calculated 10-year cardiovascular risk reduction of alirocumab and evolocumab in addition to maximal tolerated cholesterol lowering therapy: a post-commercialization study
Parth Shah, Charles J Glueck, Naila Goldenberg, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 178) with videos related to
Sort By:
Page
of 18
Lipids in Health and Disease
|
August 20, 2016
Pharmacoeconomics of PCSK9 inhibitors in 103 hypercholesterolemic patients referred for diagnosis and treatment to a cholesterol treatment center
Parth Shah, Charles J Glueck, Vybhav Jetty, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
February 23, 2024
Semaglutide improves metabolic dysfunction-associated steatohepatitis: A 10-year retrospective study
Parth Shah, Megan White, Alex Sievert, et al.
Cancers
|
November 13, 2025
Advances in Precision Oncology: From Molecular Profiling to Regulatory-Approved Targeted Therapies
Petar Brlek, Vedrana Škaro, Nenad Hrvatin, et al.
Journal of Clinical Periodontology
|
April 1, 2025
A Real-World Evidence Study Evaluating Oral-Health-Related Quality of Life Following the Use of Anti-Sensitivity Toothpaste for Self-Reported Dentine Hypersensitivity Management
Roberta Grimaldi, Sarah R Baker, Parth Shah, et al.
Croatian Medical Journal
|
June 13, 2024
Genomic sequencing for newborn screening: current perspectives and challenges
Nidhi Shah, Petar Brlek, Luka Bulić, et al.
Journal of Clinical Ultrasound : JCU
|
February 16, 2016
Predictors of incipient dysfunction of all cardiac chambers after treatment of metastatic renal cell carcinoma by tyrosine kinase inhibitors
Sherif Moustafa, Thai H Ho, Parth Shah, et al.
Preventive Medicine
|
August 3, 2021
Time and geographic variations in human papillomavirus vaccine uptake in Washington state
Nastaran Pourebrahim, Parth Shah, Trang VoPham, et al.
Lipids in Health and Disease
|
March 13, 2016
Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥ 70 mg/dl despite maximal tolerated cholesterol lowering therapy
Charles J Glueck, Parth Shah, Naila Goldenberg, et al.
Blood Advances
|
August 23, 2023
Monoallelic deletion of BCMA is a frequent feature in multiple myeloma
Mehmet Kemal Samur, Anil Aktas Samur, Jill Corre, et al.
Lipids in Health and Disease
|
January 25, 2017
Efficacy, safety, Low density lipoprotein cholesterol lowering, and calculated 10-year cardiovascular risk reduction of alirocumab and evolocumab in addition to maximal tolerated cholesterol lowering therapy: a post-commercialization study
Parth Shah, Charles J Glueck, Naila Goldenberg, et al.
Page
of 18